Aizawa Securities Group Co., Ltd. (TYO:8708)

Ligand Pharmaceuticals Revenue

Aizawa Securities Group had revenue of 4.00B JPY in the quarter ending June 30, 2025, a decrease of -17.93%. This brings the company's revenue in the last twelve months to 19.15B, up 3.27% year-over-year. In the fiscal year ending March 31, 2025, Aizawa Securities Group had annual revenue of 20.02B with 10.06% growth.

• Revenue (ttm): 19.15B
• Revenue Growth: +3.27%
• P/S Ratio: 2.22
• Revenue / Employee: 26.49M
• Employees: 723
• Market Cap: 42.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	20.02B	1.83B	10.06%
Mar 31, 2024	18.19B	5.98B	49.02%
Mar 31, 2023	12.21B	-3.41B	-21.84%
Mar 31, 2022	15.62B	-698.00M	-4.28%
Mar 31, 2021	16.32B	2.25B	15.97%